Kv7 program

Kv7 channel activation is an established concept in the treatment of treatment-resistant partial epilepsies and various pain disorders. Furthermore, we have shown that Kv7 channel activators are also highly efficacious for relaxation of overactive bladder smooth muscles, a characteristic of urinary incontinence (UI). The Saniona Kv7 channel activator program focuses on developing effective new treatments for neurological diseases, as well as finding new treatment options for patients suffering from UI. The program is in the late drug discovery phase.